Profile
Mohamed A. Genead is the founder of Aviceda Therapeutics, Inc. Dr. Genead is Chairman, President & Chief Executive Officer at Aviceda Ophthalmics, Inc. Dr. Genead is Chief Medical Officer at Ocugen, Inc. starting in 2026.
Dr. Genead was Director-Center of Retina Degenerative Diseases at the University of Illinois.
Dr. Genead was Chief Medical Officer at Gensight Biologics SA in 2017.
Dr. Genead was Chief Medical Officer at Ocugen, Inc.
Mohamed Genead active positions
| Companies | Position | Start |
|---|---|---|
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | 2026-05-07 |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Develops disease-modifying medicines through innovative technology platforms | Chief Executive Officer | - |
Former positions of Mohamed Genead
| Companies | Position | End |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 2017-10-31 |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | - |
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Ocugen, Inc.
Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Develops disease-modifying medicines through innovative technology platforms | Health Technology |
- Stock Market
- Insiders
- Mohamed Genead
















